Find Luseogliflozin manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

API REF. PRICE (USD/KG)

$
$ 0

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 898537-18-3, Luseogliflozin [inn], Ts-071, Ts-71, C596hwf74z, Chembl1093423
Molecular Formula
C23H30O6S
Molecular Weight
434.5  g/mol
InChI Key
WHSOLWOTCHFFBK-ZQGJOIPISA-N
FDA UNII
C596HWF74Z

Luseogliflozin
Luseogliflozin has been used in trials studying the treatment of Diabetes Melltius, Type 2.
1 2D Structure

Luseogliflozin

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2S,3R,4R,5S,6R)-2-[5-[(4-ethoxyphenyl)methyl]-2-methoxy-4-methylphenyl]-6-(hydroxymethyl)thiane-3,4,5-triol
2.1.2 InChI
InChI=1S/C23H30O6S/c1-4-29-16-7-5-14(6-8-16)10-15-11-17(18(28-3)9-13(15)2)23-22(27)21(26)20(25)19(12-24)30-23/h5-9,11,19-27H,4,10,12H2,1-3H3/t19-,20-,21+,22-,23+/m1/s1
2.1.3 InChI Key
WHSOLWOTCHFFBK-ZQGJOIPISA-N
2.1.4 Canonical SMILES
CCOC1=CC=C(C=C1)CC2=CC(=C(C=C2C)OC)C3C(C(C(C(S3)CO)O)O)O
2.1.5 Isomeric SMILES
CCOC1=CC=C(C=C1)CC2=CC(=C(C=C2C)OC)[C@H]3[C@@H]([C@H]([C@@H]([C@H](S3)CO)O)O)O
2.2 Other Identifiers
2.2.1 UNII
C596HWF74Z
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 1,5-anhydro-1-(5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl)-1-thioglucitol

2. Lusefi

3. Ts 071

4. Ts-071

5. Ts071 Cpd

2.3.2 Depositor-Supplied Synonyms

1. 898537-18-3

2. Luseogliflozin [inn]

3. Ts-071

4. Ts-71

5. C596hwf74z

6. Chembl1093423

7. Lusefi

8. (2s,3r,4r,5s,6r)-2-(5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2h-thiopyran-3,4,5-triol

9. (2s,3r,4r,5s,6r)-2-[5-[(4-ethoxyphenyl)methyl]-2-methoxy-4-methylphenyl]-6-(hydroxymethyl)thiane-3,4,5-triol

10. D-glucitol, 1,5-dideoxy-1,5-epithio-1-c-(5-((4-ethoxyphenyl)methyl)-2-methoxy-4-methylphenyl)-, (1s)-

11. D-glucitol, 1,5-dideoxy-1,5-epithio-1-c-[5-[(4-ethoxyphenyl)methyl]-2-methoxy-4-methylphenyl]-, (1s)-

12. Ts 071

13. Unii-c596hwf74z

14. (2s,3r,4r,5s,6r)-2-(5-((4-ethoxyphenyl)methyl)-2-methoxy-4-methylphenyl)-6-(hydroxymethyl)thiane-3,4,5-triol

15. Ts71

16. Ts071 Cpd

17. Luseogliflozin [mi]

18. Schembl1487519

19. Luseogliflozin [who-dd]

20. Dtxsid10237921

21. Chebi:134725

22. Ts071

23. Bdbm50315426

24. Akos027326750

25. Db12214

26. D-glucitol, 1,5-dideoxy-1,5-epithio-1-c-[5-[(4-ethoxyphenyl)methyl]-2-methoxy-4-methylphenyl]-, (1s)

27. A13476

28. Q27275212

29. (1s)-1,5-anhydro-1-[5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl]-1-thio-d-glucitol

2.4 Create Date
2007-02-05
3 Chemical and Physical Properties
Molecular Weight 434.5 g/mol
Molecular Formula C23H30O6S
XLogP32.9
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count7
Rotatable Bond Count7
Exact Mass g/mol
Monoisotopic Mass g/mol
Topological Polar Surface Area125
Heavy Atom Count30
Formal Charge0
Complexity514
Isotope Atom Count0
Defined Atom Stereocenter Count5
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 ATC Code

A - Alimentary tract and metabolism

A10 - Drugs used in diabetes

A10B - Blood glucose lowering drugs, excl. insulins

A10BK - Sodium-glucose co-transporter 2 (sglt2) inhibitors

A10BK07 - Luseogliflozin


Market Place

Do you need sourcing support? Ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty